FR2771292B1 - Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques - Google Patents
Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiquesInfo
- Publication number
- FR2771292B1 FR2771292B1 FR9714635A FR9714635A FR2771292B1 FR 2771292 B1 FR2771292 B1 FR 2771292B1 FR 9714635 A FR9714635 A FR 9714635A FR 9714635 A FR9714635 A FR 9714635A FR 2771292 B1 FR2771292 B1 FR 2771292B1
- Authority
- FR
- France
- Prior art keywords
- spheroids
- tiagabine
- preparation
- pharmaceutical compositions
- containing spheroids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714635A FR2771292B1 (fr) | 1997-11-21 | 1997-11-21 | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
EP98954682A EP1032391B1 (fr) | 1997-11-21 | 1998-11-19 | Spheroides contenant tiagabine, procede de preparation et compositions pharmaceutiques |
ES98954682T ES2173638T3 (es) | 1997-11-21 | 1998-11-19 | Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas. |
DK98954682T DK1032391T3 (da) | 1997-11-21 | 1998-11-19 | Sfæroider indeholdende tiagabin, fremstillingsproces og farmaceutisk sammensætning |
DE69805433T DE69805433T2 (de) | 1997-11-21 | 1998-11-19 | Tiagabin enthaltende spheroide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
PT98954682T PT1032391E (pt) | 1997-11-21 | 1998-11-19 | Esferoides contendo tiagabina processo de preparacao e composicoes farmaceuticas |
AU11703/99A AU1170399A (en) | 1997-11-21 | 1998-11-19 | Spheroids containing tiagabine, preparation process and pharmaceutical comp ositions |
AT98954682T ATE217525T1 (de) | 1997-11-21 | 1998-11-19 | Tiagabin enthaltende spheroide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
PCT/IB1998/001910 WO1999026626A1 (fr) | 1997-11-21 | 1998-11-19 | Spheroides contenant tiagabine, procede de preparation et compositions pharmaceutiques |
JP2000521828A JP2001523719A (ja) | 1997-11-21 | 1998-11-19 | チアガビンを含有するスフェロイド、製造方法および医薬組成物 |
ARP980105922 AR017652A1 (es) | 1997-11-21 | 1998-11-20 | Esferoides que contienen uno o varios principios activos excepto tiagabina, procedimiento para su preparacion, composiciones farmaceuticas que loscontienen y procedimiento para su preparacion |
ZA9810630A ZA9810630B (en) | 1997-11-21 | 1998-11-20 | Spheroids containing tiagabine preparation process and pharmaceutical compositions |
US09/198,564 US6139877A (en) | 1997-11-21 | 1998-11-23 | Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714635A FR2771292B1 (fr) | 1997-11-21 | 1997-11-21 | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2771292A1 FR2771292A1 (fr) | 1999-05-28 |
FR2771292B1 true FR2771292B1 (fr) | 2000-02-18 |
Family
ID=9513639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9714635A Expired - Fee Related FR2771292B1 (fr) | 1997-11-21 | 1997-11-21 | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
Country Status (12)
Country | Link |
---|---|
US (1) | US6139877A (fr) |
EP (1) | EP1032391B1 (fr) |
JP (1) | JP2001523719A (fr) |
AT (1) | ATE217525T1 (fr) |
AU (1) | AU1170399A (fr) |
DE (1) | DE69805433T2 (fr) |
DK (1) | DK1032391T3 (fr) |
ES (1) | ES2173638T3 (fr) |
FR (1) | FR2771292B1 (fr) |
PT (1) | PT1032391E (fr) |
WO (1) | WO1999026626A1 (fr) |
ZA (1) | ZA9810630B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
FR2771291B1 (fr) * | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
BR0009557A (pt) | 1999-04-06 | 2002-05-28 | Ethypharm Lab Prod Ethiques | Suspensão farmacêutica para beber de ibuprofeno |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
FR2845289B1 (fr) | 2002-10-04 | 2004-12-03 | Ethypharm Sa | Spheroides, procede de preparation et compositions pharmaceutiques. |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
ES2221804B1 (es) * | 2003-06-18 | 2006-04-01 | Lipofoods, S.L. | Microcapsulas para la administracion de ingredientes activos. |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
EP1802285B1 (fr) | 2004-10-21 | 2013-02-27 | Aptalis Pharmatech, Inc. | Compositions pharmaceutiques a saveur masquee avec substances porogenes gastrosolubles |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
AU2010325746B2 (en) | 2009-12-02 | 2016-02-25 | Adare Pharmaceuticals S.R.L. | Fexofenadine microcapsules and compositions containing them |
TW201127375A (en) * | 2010-01-08 | 2011-08-16 | Eurand Inc | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
MX2013009253A (es) | 2011-02-11 | 2013-12-16 | Zx Pharma Llc | Formulaciones multiparticuladas de l-mentol y metodos relacionados. |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
CA2881992C (fr) | 2013-04-23 | 2016-11-22 | Zx Pharma, Llc | Composition multiparticulaire, revetue, enterique, a liberation controlee d'huile de menthe poivree et procedes associes |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684516A (en) * | 1983-08-01 | 1987-08-04 | Alra Laboratories, Inc. | Sustained release tablets and method of making same |
JPS62153213A (ja) * | 1985-12-26 | 1987-07-08 | Dai Ichi Seiyaku Co Ltd | 腸溶性粒状物 |
NZ230763A (en) * | 1988-09-27 | 1991-10-25 | Takeda Chemical Industries Ltd | Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient |
JP2572673B2 (ja) * | 1990-07-25 | 1997-01-16 | エスエス製薬株式会社 | 徐放性錠剤 |
DK58291D0 (da) * | 1991-04-02 | 1991-04-02 | Novo Nordisk As | Krystalinsk stof og dets fremstilling |
ZA923474B (en) * | 1991-05-20 | 1993-01-27 | Marion Merrell Dow Inc | Diltiazem formulation |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
WO1995005808A1 (fr) * | 1993-08-24 | 1995-03-02 | Abbott Laboratories | Procede de production de comprimes a base d'huile |
US5430021A (en) * | 1994-03-18 | 1995-07-04 | Pharmavene, Inc. | Hydrophobic drug delivery systems |
US5484608A (en) * | 1994-03-28 | 1996-01-16 | Pharmavene, Inc. | Sustained-release drug delivery system |
US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
US5750140A (en) * | 1994-05-20 | 1998-05-12 | Novo Nordisk A/S | Transdermal delivery of tiagabine |
ATE211911T1 (de) * | 1995-05-05 | 2002-02-15 | Novo Nordisk As | Tiagabinhydrochlorid enthaltendes arzneimittel und verfahren zu dessen herstellung |
US5914333A (en) * | 1996-07-31 | 1999-06-22 | Novo Nordisk A/S | Treatment of psychotic disorders |
HU228855B1 (en) * | 1997-03-12 | 2013-06-28 | Abbott Lab | Hydrophilic binary systems for the administration of cyclosporine |
-
1997
- 1997-11-21 FR FR9714635A patent/FR2771292B1/fr not_active Expired - Fee Related
-
1998
- 1998-11-19 EP EP98954682A patent/EP1032391B1/fr not_active Expired - Lifetime
- 1998-11-19 ES ES98954682T patent/ES2173638T3/es not_active Expired - Lifetime
- 1998-11-19 JP JP2000521828A patent/JP2001523719A/ja active Pending
- 1998-11-19 PT PT98954682T patent/PT1032391E/pt unknown
- 1998-11-19 DE DE69805433T patent/DE69805433T2/de not_active Expired - Lifetime
- 1998-11-19 WO PCT/IB1998/001910 patent/WO1999026626A1/fr active IP Right Grant
- 1998-11-19 AT AT98954682T patent/ATE217525T1/de active
- 1998-11-19 AU AU11703/99A patent/AU1170399A/en not_active Abandoned
- 1998-11-19 DK DK98954682T patent/DK1032391T3/da active
- 1998-11-20 ZA ZA9810630A patent/ZA9810630B/xx unknown
- 1998-11-23 US US09/198,564 patent/US6139877A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE217525T1 (de) | 2002-06-15 |
PT1032391E (pt) | 2002-09-30 |
FR2771292A1 (fr) | 1999-05-28 |
US6139877A (en) | 2000-10-31 |
DE69805433D1 (de) | 2002-06-20 |
AU1170399A (en) | 1999-06-15 |
EP1032391A1 (fr) | 2000-09-06 |
EP1032391B1 (fr) | 2002-05-15 |
DE69805433T2 (de) | 2002-11-07 |
DK1032391T3 (da) | 2002-09-09 |
WO1999026626A1 (fr) | 1999-06-03 |
ES2173638T3 (es) | 2002-10-16 |
JP2001523719A (ja) | 2001-11-27 |
ZA9810630B (en) | 1999-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2771291B1 (fr) | Spheroides, procede de preparation et compositions pharmaceutiques | |
FR2771292B1 (fr) | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques | |
FI20011852A (fi) | Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi | |
GEP20002211B (en) | Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same | |
ATE146360T1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
PT839149E (pt) | Derivados da galantamina processo de sua preparacao sua aplicacao como medicamento e as composicoes farmaceuticas que as contem | |
DE69836678D1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
ATE332894T1 (de) | Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
AU3777197A (en) | Cyclosporin formulation | |
AU7775398A (en) | Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions | |
BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
UA74388C2 (uk) | Фармацевтичні композиції тизоксаніду і нітазоксаніду | |
MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
DE69509643T2 (de) | Sesquiterpenderivate | |
IT1290910B1 (it) | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive | |
FR2809725B1 (fr) | Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant | |
FR2652590B1 (fr) | Exopolymere extracellulaire, son procede de preparation et compositions pharmaceutiques le contenant. | |
AU2506188A (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
SE9803277D0 (sv) | Novel compounds | |
TNSN96062A1 (fr) | Benzocyclopentane-oxazolidinones contenant des heteroatomes. | |
UA10234A (uk) | Спосіб лікування цукрового діабету | |
GT199400048A (es) | Composicion farmaceutica y proceso para su preparacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GC | Lien (pledge) constituted | ||
ST | Notification of lapse | ||
GC | Lien (pledge) constituted |
Effective date: 20140519 |
|
GC | Lien (pledge) constituted |
Effective date: 20160120 |
|
RG | Lien (pledge) cancelled |
Effective date: 20160226 |
|
RG | Lien (pledge) cancelled |
Effective date: 20170418 |